- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ALK-positive Non-small Cell Lung Cancer (NSCLC) in Korea, Republic of
Total 952 results
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityUnknown
-
Korea Institute of Oriental MedicineRecruitingNon-small Cell Lung CancerKorea, Republic of
-
Yuhan CorporationSeoul National University HospitalCompletedNon-Small Cell Lung CancerKorea, Republic of
-
Daiichi SankyoRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Japan, Netherlands, Taiwan
-
Samsung Medical CenterCompletedCarcinoma, Non-Small Cell LungKorea, Republic of
-
AstraZenecaCompletedNon Small Cell Lung CarcinomaKorea, Republic of
-
Samsung Medical CenterRecruitingNon-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterCompleted
-
Myung-Ju AhnRecruitingNSCLCKorea, Republic of
-
Chonnam National University HospitalAstraZenecaUnknownNon-Small Cell Lung CancerKorea, Republic of
-
Yonsei UniversityCompletedNon-small Cell Lung CarcinomaKorea, Republic of
-
Samsung Medical CenterNot yet recruitingMetastatic Lung Non-Small Cell Carcinoma | EGFR T790MKorea, Republic of
-
AstraZenecaParexelRecruitingNon-Small Cell Lung Cancer (NSCLC)Korea, Republic of, Malaysia, Taiwan, Thailand, Hong Kong, Singapore, Canada
-
Samsung Medical CenterRecruitingMetastatic Non-Small Cell Lung CarcinomaKorea, Republic of
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerChina, Korea, Republic of, Taiwan
-
National Cancer Center, KoreaUnknownLung CancerKorea, Republic of
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Samsung Medical CenterRecruitingNon Small Cell Lung Cancer | Brain MetastasesKorea, Republic of
-
National Cancer Center, KoreaUnknownLung CancerKorea, Republic of
-
Bridge Biotherapeutics, Inc.RecruitingEGFR Mutant Advanced Non-Small Cell Lung CancerKorea, Republic of, United States
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Taiwan, Japan
-
AstraZenecaQuintiles, Inc.CompletedNon Small Cell Lung CancerKorea, Republic of, Spain, France
-
Turning Point Therapeutics, Inc.TerminatedNon-Small Cell Lung Cancer | NSCLC | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | ALK Gene MutationUnited States, Australia, Korea, Republic of
-
AstraZenecaActive, not recruitingMetastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, Belgium, Poland, Taiwan, Thailand, Korea, Republic of, Russian Federation, Austria
-
Clovis Oncology, Inc.TerminatedSmall Cell Lung Cancer | Non-Small Cell Lung Cancer | NSCLC | Lung Cancer | Metastatic Lung Cancer | SCLC | Stage IV Lung Cancer | Advanced Lung Cancer | Squamous Non-Small Cell Lung CancerUnited States, Italy, Germany, France, Spain
-
Yuhan CorporationThe Korean Academy of Tuberculosis and Respiratory DiseasesActive, not recruiting
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Samsung Medical CenterActive, not recruitingNon-Small Cell Lung Cancer With EGFR T790M Mutation | With Brain and/or Leptomeningeal Metastasis | Failed Tyrosine Kinase InhibitorsKorea, Republic of
-
Dong-A University HospitalCompletedColorectal Cancer | Pancreatic Cancer | Non-small Cell Lung CancerKorea, Republic of
-
AbbViePfizerActive, not recruitingCancer | Non-small Cell Lung Cancer (NSCLC)United States, Israel, Japan, Korea, Republic of, Spain, Taiwan
-
PfizerCompletedNon-small Cell Lung CancerKorea, Republic of, United States
-
Ono Pharmaceutical Co. LtdCompletedAdvanced Non-small Cell Lung CancerKorea, Republic of
-
Dong-A University HospitalCompletedPancreatic Cancer | Non-small Cell Lung CancerKorea, Republic of
-
AstraZenecaParexelTerminatedNon Small Cell Lung CancerUnited States, Korea, Republic of
-
Samsung Medical CenterUnknownNonsmall Cell Lung CancerKorea, Republic of
-
PfizerCompletedCarcinoma, Non Small Cell LungKorea, Republic of
-
Rain Oncology IncTerminatedNSCLC | Non-small Cell Lung Cancer | Non-squamous NSCLCUnited States, Australia
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
Se-Hoon LeeTerminatedAZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer (SUKSES-N5)SCLC, RecurrentKorea, Republic of
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan
-
Astex Pharmaceuticals, Inc.CompletedNon-small Cell Lung Cancer(NSCLC)United States, Korea, Republic of, Spain, France, Canada
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerFrance, Korea, Republic of, United Kingdom, Spain
-
Novartis PharmaceuticalsNo longer availableNon-small Cell Lung Cancer (NSCLC)United States, Argentina, Korea, Republic of, Hong Kong, Thailand, Mexico, Jordan, Colombia, India, Philippines
-
Bridge Biotherapeutics, Inc.TerminatedNSCLCKorea, Republic of
-
Therapex Co., LtdRecruitingCarcinoma, Non-Small-Cell Lung | EGFR Mutant Advanced Non-Small Cell Lung CancerKorea, Republic of
-
Wellmarker BioMerck Sharp & Dohme LLCRecruitingHead and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Advanced Solid Tumor | Metastatic Solid TumorKorea, Republic of
-
Hoffmann-La RocheActive, not recruitingAnaplastic Lymphoma Kinase-positive Non-small Cell Lung CancerChina, Korea, Republic of, Thailand
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
Symphogen A/SCompletedNSCLC | Non Small Cell Lung Cancer | Oncology | MET Gene Mutation | MET Gene AmplificationUnited States, Korea, Republic of, Denmark, Hong Kong, Taiwan, Spain